Scroll Top

WHO WE ARE?

Revolutionizing Healthcare with AI and MicroRNA Technology

CureLogic is a groundbreaking med-tech company harnessing the power of advanced AI to revolutionize personalized medicine. Our proprietary technology rapidly develops targeted microRNA treatments, delivering fast and reliable solutions for critical health conditions.
Focusing on heart disease and cancer, two of the deadliest global health threats, we create personalized therapies designed for maximum accuracy and effectiveness for each individual patient.

Our services

At CureLogic, we offer a range of services that are designed to empower both healthcare
providers and patients. Whether it’s through AI powered diagnosis or personalized treatment
recommendations, we provide tools that make healthcare smarter, faster, and more
accurate. Smarter Healthcare Solutions at Your Fingertips. Here’s a look at how we are making a difference:

AI-Based Diagnosis & Care

Our platform uses artificial intelligence to analyze a patient’s health data, making it easier for doctors to recommend the most effective treatments.

Personalized MicroRNA Based Treatment

We are at the forefront of microRNA technology, which allows us to create highly personalized treatments tailored to the patient’s unique genetic profile.

Health Data Analytics

We transform medical data into actionable insights, empowering doctors and patients to make informed decisions and improve outcomes.

Cost Effective Treatment Plans

We understand that healthcare costs can be a major barrier to getting the right treatment.

PROJECTS

Real Stories of Smarter Healthcare

 

At CureLogic, we are using AI and data to make healthcare more personal, accurate, and effective. Our platform is already helping doctors and patients in areas where it’s needed the most.

CLIENTS

Built for Doctors, Loved by Patients

Hospitals & Medical Teams
We give hospitals, clinics, home care facilities, and doctors the tools to make quicker, smarter decisions with less guesswork. With a simple yearly license, they get access to our AI-powered system to create precise and personalized treatments focused on individual patient results, generating the precise signature drug treatment personalized to treat any disease.

Everyday Patients
Medical Board Certified Doctors can thus create an account, answer the required pertinent patient-related health questions, and get an AI-powered health report and a personalized treatment plan. It helps patients with a more effective and precise treatment plan for their conditions.

CureLogic is designed for the people at the heart of healthcare - doctors, hospitals, and patients.

OUR TEAM
Meet the People Behind the Mission

We are a team of bioscientists, bioengineers, mathematicians, medical doctors, tech experts, scientists, and healthcare thinkers, all brought together by one goal: to change how healthcare works.

By combining AI with real medical experience, we are building tools that help people live healthier lives longer. We believe in smart, human-centred healthcare where every decision is backed by data and made with care.

Gwen Swan
CEO

Gwen Swan is a forward-thinking professional currently contributing her skills and insights at CureLogic.

Dr. Rob Krams
CSO

Professor Krams was trained at the Free University Amsterdam, where he did his PhD

Dr Lorenzo Jamone
Robotics Specialist

Associate Professor in Robotics & AI at the Department of Computer Science of University College London (UCL)

CureLogic
Key Aspects of Precision Medicine
CureLogic focuses on providing precision medicine treatment solutions tailored for patients with various diseases. This approach emphasizes personalized healthcare, utilizing individual genetic, environmental, and lifestyle information to guide treatment decisions.
  • Personalized Treatment
  • Data Utilization
  • Broad Applications
CURELOGIC

Precision Medicine Treatment Solutions for Any Patient with Any Disease

AI Diagnosis & Treatment

AI analyzes patient data to guide precise, effective treatment decisions.

Health Data Analytics

We don’t just collect data, we turn it into meaningful insights.

Cost-Effective Treatment Plans

We understand that healthcare costs can be a significant barrier to getting the right treatment.

Personalized microRNA Therapy

Tailored treatments using advanced microRNA tech, guided by each patient’s genetic profile.

Heart Health

AI-driven insights for precise treatment of heart failure and coronary artery disease.

Better Cancer Care

AI enables early cancer detection and personalized treatment plans based on individual health profiles.

Treating Genetic Diseases

Diseases like cystic fibrosis or Huntington’s disease are rare, and our platform helps doctors understand and treat any genetic diseases better using personalized genetic insights and microRNA-based solutions.

AI-Powered Diagnosis and Treatment Recommendations
Personalized MicroRNA-Based Treatment
Health Data Analytics
Cost-Effective Treatment Plans
Personalized Precision Medicine

Disease progression depends on individual factors including genetic, genomic, proteomic, and environmental factors. These need different dosages and different therapeutics during their progression.

01
Precision medicine’s
Precision medicine’s first step is toward making personalised medicine dosages relevant to the specific patient by implementing large data set analysis.
02
Personalised medicine
Personalised medicine aims at using the genetic profile of the individual patient to better treat the disease.
03
The Problematic
The Problematic is that the current drug arsenal utilise approximately ~8,000 to 20,000 APIs is not sufficient to treat any disease ~35,000, nor to include diseases’ progress levels which would require at least ~100,000
Investor Relations

Meet a Crew of Professionals

CureLogic seeks £3M, split into two £1.5M rounds. The initial £1.5M will fund lab setup, staffing, consumables, and development of our automated AI and AI-CRISPR platform. It also covers launch-related marketing. The platform targets two markets: University labs – Expected revenue: £1M in Year 1, growing to £5M+ Hospitals (NHS/EU) – Revenue begins post-regulatory approval, expected within the first year.
rob-investor
Rob Krams
Founder
rob.krams@curelogic.org
gwen-investor
Gwen Swan
Founder
gwen.swan@curelogic.org
Let’s make something together

We’d be glad to hear from you. Please feel free to reach out with any inquiries or opportunities for collaboration.